Indivior Pharmaceuticals, Inc.
INDV
$34.41
-$0.36-1.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 577.78% | 89.36% | 385.71% | 95.45% | 118.56% |
| Total Depreciation and Amortization | -40.00% | -20.00% | -16.67% | -37.50% | -16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 200.00% | 916.67% | -174.36% | 0.00% | 208.33% |
| Change in Net Operating Assets | -47.54% | -1,058.82% | -247.67% | -155.26% | -36.13% |
| Cash from Operations | 44.94% | -112.00% | -1,200.00% | -2,050.00% | 79.55% |
| Capital Expenditure | 58.82% | -300.00% | -50.00% | -185.71% | -325.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash from Investing | 52.94% | -280.00% | -400.00% | -157.14% | -1,800.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -8,225.00% | 97.90% | -300.00% | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00% | -- |
| Repurchase of Common Stock | -- | -1,045.45% | 96.15% | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 400.00% | -666.67% | 200.00% | -100.00% | -- |
| Cash from Financing | -3,360.00% | 141.18% | -112.50% | 94.12% | 85.71% |
| Foreign Exchange rate Adjustments | -- | -- | -100.00% | -100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -150.00% | -- | -- | -- | -- |
| Net Change in Cash | -65.94% | -137.74% | -881.25% | -333.33% | 155.56% |